Dermatology News

In September 2022, the FDA approved deucravacitinib for moderate-to-severe plaque psoriasis, officially introducing tyrosine kinase 2 inhibition to clinics across the United States.

The list prices of Stelara and Enbrel for Medicare users will be discounted nearly 70% come 2026 as a result of the first round CMS price negotiations with drugmakers, the White House has announced.

Medicine was an interesting thought as I was growing up with no medical people in my family.

Intravenous immunoglobulin treatment may benefit skin, musculoskeletal and gastrointestinal manifestations of systemic sclerosis, with low risks for adverse events, according to data published in Seminars in Arthritis and Rheumatism.

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

A generally healthy 42-year-old female presents for evaluation of anxiety, tremors, weight loss, loose stools and heart racing. Symptoms began shortly after she was let go at work about 4 months ago.

Topically applied nanoparticle-encapsulated cannabidiol cream helped prevent and repair damage to the skin from ultraviolet A radiation, according to a first-of-its-kind study.

Patients with psoriasis, specifically those with a high BMI, had lower concentrations of polyunsaturated fatty acids and elevated concentrations of saturated fatty acid, which correlate to greater disease severity, according to a study.

While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.